Status:
COMPLETED
Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea
Lead Sponsor:
Eastern Virginia Medical School
Collaborating Sponsors:
Medarva
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
2-16 years
Brief Summary
Investigate urinary leukotriene E4 levels and determine if there is a correlation with severity of obstructive sleep apnea. The investigators then would like to determine a threshold level which could...
Eligibility Criteria
Inclusion
- children 2-16 years of age
- scheduled for polysomnogram
Exclusion
- cardiovascular, neuromuscular, immunologic or craniofacial disorders
- pharmacologic treatment including corticosteroids and leukotriene receptor antagonists in the last month
- subjects who have already received treatment for OSA with an oral appliance, continuous positive airway pressure (CPAP) device
- previously undergone tonsillectomy and/or adenoidectomy
Key Trial Info
Start Date :
February 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT02205346
Start Date
February 1 2014
End Date
December 1 2016
Last Update
February 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of the King's Daughters
Norfolk, Virginia, United States, 23507